Biomarker Trio Shows Promise for Monitoring CKD

TOPLINE: The choice of renal replacement therapy, along with factors such as dialysis duration and cause and stage of chronic kidney disease (CKD), can affect the levels of renalase, dopamine, and norepinephrine in patients with CKD, highlighting the importance of monitoring these levels for predicting disease progression and the risk for cardiovascular events…